$20.31
-0.32-1.55%
At close: -
$20.31
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Celldex Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:CLDX | Benzinga
Celldex Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 11
EPS Estimate
$-0.730
Quarterly Revenue Estimate
$1.31M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$9.98M
Analyze the earnings history of Celldex Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Celldex Therapeutics (CLDX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-06 | $-0.64 | $-0.68 | 5.88 % |
| Q2 | 2024-08-08 | $-0.54 | $-0.60 | 10.0 % |
| Q1 | 2024-05-06 | $-0.56 | $-0.69 | 18.8 % |
| Q4 | 2024-02-26 | $-0.83 | $-0.74 | -12.2 % |
Celldex Therapeutics (CLDX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-06 | $3.19M | $920.00K | 246.9 % |
| Q2 | 2024-08-08 | $2.50M | $820.43K | 204.5 % |
| Q1 | 2024-05-06 | $156.00K | $920.00K | -83.0 % |
| Q4 | 2024-02-26 | $4.13M | $840.00K | 391.9 % |
FAQ
When is Celldex Therapeutics (NASDAQ:CLDX) reporting earnings?
Celldex Therapeutics (CLDX) is scheduled to report earnings on May 5, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
What were the latest earnings per share (EPS) for Celldex Therapeutics (NASDAQ:CLDX)?
The Actual EPS was $-0.64, which beat the estimate of $-0.68.
What were Celldex Therapeutics’s (NASDAQ:CLDX) revenues?
The Actual Revenue was $3.2M, which beat the estimate of $920K.
Browse earnings estimates, EPS, and revenue on all stocks.